| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.84 | 0.04 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.26 | 5e-05 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.22 | 5e-06 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |